"Nanospectra Biosciences, Inc. - Product Pipeline Analysis" Now Available at Fast Market Research
Nanospectra Biosciences, Inc. (Nanospectra) is a medical device company, based in the US. The company develops and commercializes particle-based therapies for the selective and precise thermal destruction of solid tumors. It provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. The company also offers research-use-only nanoparticles with specific optical characteristics. It has an open investigational device exemption (IDE) to evaluate the safety and efficacy of aurolase therapy for the treatment of refractory head...
View full press release